Eyenovia, Inc. Profile Avatar - Palmy Investing

Eyenovia, Inc.

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutica…

Biotechnology
US, New York [HQ]

Resulting Ratios

9 Records · Starting from 2015
Loading...
End of EYEN's Analysis
CIK: 1682639 CUSIP: 30234E104 ISIN: US30234E1047 LEI: - UEI: -
Secondary Listings
EYEN has no secondary listings inside our databases.